X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
Tags:
KENILWORTH, N.J.--(BUSINESS WIRE)--Sep 21, 2020... [Read More]
We now have the official clinical trial designs for the three biggest and most advanced coronavirus vaccine trials: Moderna, Pfizer/BioNTech and Oxford/AstraZeneca. Now, as for... [Read More]
KENILWORTH, N.J.--(BUSINESS WIRE)--Sep 21, 2020--AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for... [Read More]
The European Medicines Agency (EMA) has recommended approval for Lynparza in patients with a form of prostate cancer and as a first-line maintenance treatment for... [Read More]
KENILWORTH, N.J., & WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Sep 20, 2020... [Read More]
KENILWORTH, N.J.--(BUSINESS WIRE)--Sep 20, 2020... [Read More]
KENILWORTH, N.J., & BRUSSELS--(BUSINESS WIRE)--Sep 19, 2020... [Read More]
Thumbnail
AstraZeneca (AZN) resumes its coronavirus vaccine study in the United Kingdom. Merck (MRK) inks two oncology deals with Seattle Genetics. [Read More]
WILMINGTON, Del.--(BUSINESS WIRE)--Sep 18, 2020--AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) today announced that LYNPARZA demonstrated a... [Read More]
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced... [Read More]
CMO Conference Call Participants Louise Chen... [Read More]
Sorrento Therapeutics (NASDAQ:SRNE) +30% on FDA nod for early-stage COVID-19 antibody trial.Hepion Pharmaceuticals (NASDAQ:HEPA) +25% on positive activity of CRV431 against Coronavirus SARS-2 in study conducted by the NIAID.Vaccinex... [Read More]
Pharmaceutical companies including Novartis, Merck, and AstraZeneca have successfully deployed a federated learning platform for drug discovery. [Read More]
Baum Hedlund Aristei & Goldman filed a Gardasil vaccine injury lawsuit today against manufacturer Merck on behalf of a young man who sustained... [Read More]
17.7B and EBITDA pre in a range of € 4.45B... [Read More]
17.7B and EBITDA pre in a range of € 4.45B... [Read More]
The biotech sector remains in focus with regulatory and other pipeline updates. [Read More]
KENILWORTH, N.J.--(BUSINESS WIRE)--Sep 16, 2020... [Read More]
When Merck and Co. requested that Elkton change the name of Stonewall Riverside Park, the town was left with two options - drop "Stonewall" or... [Read More]
Merck KGaA on Wednesday backed its outlook for the full year, and said it is currently focusing on organic growth and lowering its debt. The... [Read More]
Loading...
Save As
Preview
Preview